Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: J Pediatr Gastroenterol Nutr. 2010 May;50(5):526–530. doi: 10.1097/MPG.0b013e3181cea48d

Table 1.

Clinical Characteristics of Study Participants at Time of Hepatic Classification

Clinical Data Relevant for Hepatic Stratification Mild Patients
Biochemical abnormalities without cholestasis 2
Cholestasis but no pruritus (no medications) 5
Cholestasis and pruritus responsive to medications 15
Severe Patients
Severe cholestasis with pruritus, unresponsive to medication 1
Severe cholestasis with cirrhosis and portal hypertension 2
Biliary diversion for severe cholestasis and intractable pruritus 1
Transplantation for profound cholestasis 5
Transplantation for complications of portal hypertension 2

Cholestasis defined by

• Conjugated bilirubin > 2mg/dL, or

• GGT > 3x upper limit of normal, or